577 filings
Page 6 of 29
EFFECT
jbpdmzy0
15 Apr 19
Notice of effectiveness
12:16am
UPLOAD
6x9xidlw2fib1cu
15 Apr 19
Letter from SEC
12:00am
CORRESP
yvnbn6pqywcamvxv
11 Apr 19
Correspondence with SEC
12:00am
CORRESP
8v9eu 13yx9nthh
11 Apr 19
Correspondence with SEC
12:00am
S-8
6cs38k s9dz5rm4zi
4 Apr 19
Registration of securities for employees
5:03pm
8-K
0bew49lve7y28az5 fw
1 Apr 19
Results of Operations and Financial Condition
4:25pm
8-K
igaasob
15 Mar 19
Departure of Directors or Certain Officers
5:01pm
424B2
qrn1oen zu
11 Mar 19
Prospectus for primary offering
8:49am
8-K
qqr6736 i0v0k
11 Mar 19
Altimmune Announces $14 million Registered Direct Offering
8:45am
8-K
wuechy3anl
8 Mar 19
Altimmune Announces Clinical Program Updates and Plans for Pipeline Expansion
6:04am
8-K
xpropo
3 Dec 18
Departure of Directors or Certain Officers
12:00am
S-8
r65z53
30 Nov 18
Registration of securities for employees
4:41pm
8-K
icxv9zusitxjm6zqpgw0
30 Nov 18
Other Events
4:14pm
8-K
czpgng
27 Nov 18
Altimmune Appoints Vipin K. Garg, Ph.D. as its New President and Chief Executive Officer
4:34pm
8-K
yldoonpc x1
13 Nov 18
Altimmune Announces Third Quarter 2018
4:57pm
8-K
g17c5rej5 b3
22 Oct 18
Departure of Directors or Certain Officers
4:30pm